Biotech Tricopharming Research — Seed · €480K

Tricopharming closed a €480K round that brought in Kira Ventures, Sancus Capital (which it met through Decelera's September 2021 programme) and the private investor Pedro Díaz Montañez. No lead was named. The money went to the market launch of its MapStimulants biostimulant line, including TricoStimulant. The sources give no exact date: the round followed the Decelera programme of September 2021 and ran alongside the NEOTEC 2021 grant (project period 2022), so it is filed as 2022-01 by year only. Over the same months the company also secured a €260K CDTI NEOTEC grant and a €200K ENISA loan under the AgroInnpulso line. Neither is part of the round.